Reduced in vivo bile acid synthesis in miniswine on total parenteral nutrition (TPN)

1995 ◽  
Vol 108 (4) ◽  
pp. A1057
2007 ◽  
Vol 194 (5) ◽  
pp. 623-627 ◽  
Author(s):  
Lillian G. Dawes ◽  
Harrison C. Laut ◽  
Marilyn Woodruff

2008 ◽  
Vol 196 (3) ◽  
pp. 461-462
Author(s):  
Ismail Bilgic ◽  
M. Tahir Oruc ◽  
M. Mahir Ozmen

2020 ◽  
Vol 61 (11) ◽  
pp. 1450-1463 ◽  
Author(s):  
Solenne Marion ◽  
Lyne Desharnais ◽  
Nicolas Studer ◽  
Yuan Dong ◽  
Matheus D. Notter ◽  
...  

Bile acids, which are synthesized from cholesterol by the liver, are chemically transformed along the intestinal tract by the gut microbiota, and the products of these transformations signal through host receptors, affecting overall host health. These transformations include bile acid deconjugation, oxidation, and 7α-dehydroxylation. An understanding of the biogeography of bile acid transformations in the gut is critical because deconjugation is a prerequisite for 7α-dehydroxylation and because most gut microorganisms harbor bile acid transformation capacity. Here, we used a coupled metabolomic and metaproteomic approach to probe in vivo activity of the gut microbial community in a gnotobiotic mouse model. Results revealed the involvement of Clostridium scindens in 7α-dehydroxylation, of the genera Muribaculum and Bacteroides in deconjugation, and of six additional organisms in oxidation (the genera Clostridium, Muribaculum, Bacteroides, Bifidobacterium, Acutalibacter, and Akkermansia). Furthermore, the bile acid profile in mice with a more complex microbiota, a dysbiosed microbiota, or no microbiota was considered. For instance, conventional mice harbor a large diversity of bile acids, but treatment with an antibiotic such as clindamycin results in the complete inhibition of 7α-dehydroxylation, underscoring the strong inhibition of organisms that are capable of carrying out this process by this compound. Finally, a comparison of the hepatic bile acid pool size as a function of microbiota revealed that a reduced microbiota affects host signaling but not necessarily bile acid synthesis. In this study, bile acid transformations were mapped to the associated active microorganisms, offering a systematic characterization of the relationship between microbiota and bile acid composition.


1996 ◽  
Vol 15 ◽  
pp. 32
Author(s):  
M. Yano ◽  
A. Ogawa ◽  
T. Tsujinaka ◽  
C. Ebisui ◽  
T. Morimoto ◽  
...  

2020 ◽  
Vol 318 (1) ◽  
pp. G41-G52 ◽  
Author(s):  
Gregory Guthrie ◽  
Barbara Stoll ◽  
Shaji Chacko ◽  
Charlotte Lauridsen ◽  
Jogchum Plat ◽  
...  

Infants receiving long-term parenteral nutrition (PN) develop PN-associated liver disease (PNALD). We previously (Ng K et al. JPEN J Parenter Enteral Nutr 40: 656–671, 2016. doi: 10.1177/0148607114567900 .) showed that PN containing soy-based lipid supplemented with vitamin E (α-tocopherol) prevents the development of PNALD. We hypothesize that this occurs via vitamin E activation of pregnane X receptor (PXR)-mediated pathways involved in bile acid metabolism. Neonatal piglets received PN for 14 days containing Intralipid (IL; soy-based lipid emulsion), IL supplemented with 12.6 mg·kg−1·day−1 vitamin E (VITE), or IL with 10 mg·kg−1·day−1 Rifadin IV (RIF), a PXR agonist. Pigs treated with IL and VITE, but not RIF, developed cholestasis and hyperbilirubinemia, markers of liver disease. The hepatic PXR target genes CYP3A29 and UGT1A6 increased during RIF treatment. RIF also modestly increased metabolism of chenodeoxycholic acid to the more hydrophilic bile acid hyocholic acid. Serum fibroblast growth factor (FGF)-19, a key regulator in suppressing hepatic bile acid synthesis, significantly increased in the RIF group. We conclude rifampicin modified markers of PNALD development by increased metabolism of bile acids and potentially suppressed bile acid synthesis. Vitamin E was ineffective at high lipid doses in preventing PNALD. NEW & NOTEWORTHY Intravenous vitamin E and rifampicin were administered to neonatal piglets receiving parenteral nutrition to determine their efficacy in reducing the progression of parenteral nutrition-associated liver disease (PNALD). Rifampicin increased serum FGF-19 concentrations and synthesis of the bile acid hyocholic acid which led to a reduction of PNALD parameters at 2 wk of administration. This result has potential clinical implications for the use of rifampicin as a safe and inexpensive treatment for short-term development of PNALD.


2007 ◽  
Vol 149 ◽  
pp. S75-S76 ◽  
Author(s):  
Marina Del Puppo ◽  
Federica Corna ◽  
Maria Teresa Dotti ◽  
Emma De Fabiani ◽  
Marzia Galli Kienle

1988 ◽  
Vol 82 (1) ◽  
pp. 82-85 ◽  
Author(s):  
W C Duane ◽  
P A Pooler ◽  
J N Hamilton

Sign in / Sign up

Export Citation Format

Share Document